Future studies of KS will need to incorporate specific HAART regimens and degree of immunosuppression, as measured by cluster of differentiation 4 (CD4) counts and HIV viral loads, in order to study the effects of particular treatment regimens and determine the relationship between immunosuppression and survival. This evidence concerns the gene CD4 and Kaposi's sarcoma.